Learning the Lingo for Big-Ticket Grants

Courtesy of Moffa Photography Work continues on a method for setting priorities for big research projects at the National Science Foundation, an effort that started in 1991 when Congress asked for help in weighing competing proposals. Lawmakers say they simply cannot understand the big-ticket requests for funding of major research equipment and new facilities that turn up in NSF's budget. Because of the large expense, proposals to build a string of ocean observatories, for one example, or to i

Written byPeg Brickley
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Work continues on a method for setting priorities for big research projects at the National Science Foundation, an effort that started in 1991 when Congress asked for help in weighing competing proposals. Lawmakers say they simply cannot understand the big-ticket requests for funding of major research equipment and new facilities that turn up in NSF's budget. Because of the large expense, proposals to build a string of ocean observatories, for one example, or to improve the South Pole station where NSF funds support extensive biological research, for another, must go to Congress as part of the agency's budget request.

Budget items queue up for a wait that may last years, with tens to hundreds of millions of dollars hanging in the balance. Projects that already have NSF backing and need more equipment or a new facility generally move to the head of the line, as do research projects tied to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies